Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Endologix Reveals Positive Clinical Data From Nellix EVAS FORWARD-IDE Study

By: via Benzinga
Endologix, Inc. (NASDAQ: ELGX) revealed positive clinical data from the Nellix investigational device exemption (IDE) clinical study, ...
Related Stocks:
Endologix Inc
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.